Abstract:In early-stage cervical cancer, lymph node status is of paramount importance to determine the best therapeutic strategy and is one of the most important prognostic factors of survival. According to main international guidelines, pelvic full lymphadenectomy is recommended for lymph node staging. Sentinel lymph node (SLN) biopsy is an accurate method for the assessment of lymph nodal involvement and has been suggested instead of systematic pelvic lymph node dissection (PLND). The SLN technique requires a learning-curve to be well performed. Combined detection with technetium-99 and blue dye has been widely used but the recent introduction of indocyanine green (ICG) is of growing interest since it could improve SLN detection. SLN biopsy offers a more accurate anatomical staging by finding potential metastatic nodes outside of usual lymphadenectomy areas. SLN biopsy improves the diagnostic value of lymph node staging with ultrastaging and detection of low-volume nodal metastases [isolated tumor cells (ITCs) and micrometastases]. Appropriate selection of patient and minimal training combined with some simple rules may guarantee a low false negative rate. Several studies have shown that SLN mapping in these patients is feasible, with excellent detection rates and sensitivity. Less-radical lymph node dissection decreases the associated morbidity of PLND, especially the risk of lower-limb lymphoedema, which severely affects patient quality of life. Some points are still subject to debate such as the low accuracy of intraoperative SLN status assessment by frozen section and the impact of micrometastasis on prognosis. Although international guidelines consider SLN biopsy as an alternative to PLND, SLN biopsy alone is not the gold-standard yet due to lack of prospective evidence on long-term oncological safety. The 3 ongoing prospective trials SENTIX, PHENIX and SENTICOL III will most probably give an answer to these issues.

Further development of sentinel lymph nodes detection by nuclear medicine

Clinical Study of Sentinel Lymph Node Biopsy in Colon Cancer

High Risk For Non-Sentinel Node Metastasis In Breast Cancer Patients With Sentinel Node Metastases

Advances in Exploring Localization and Biopsy of Sentinel Lymph Node with Vital Dye

Advances on the Study of Sentinel Lymph Node in Gastric Cancer

Current studies and evaluations of sentinel lymph node biopsy for breast cancer

[Sentinel Lymph Node Detection and Intra-Operational Diagnosis in Patients with Early Stage Cervical Cancer].

Research Progress of Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy for Breast Cancer

Sentinel Lymph Node Mapping: Current Applications and Future Perspectives in Gynecology Malignant Tumors

Sentinel Lymph Node Biopsy with a Novel Sentinel Lymphoscintigraphy Agent 99Mtc-Rituximab for Breast Cancer

Sentinel lymph node in cervical cancer: time to move forward

Mammary sentinel lymphoscintigraphy in breast cancer

Progress of sentinel lymph node tracer agents in breast cancer

Near-infrared-II ratiometric fluorescence probes for non-invasive detection and precise navigation surgery of metastatic sentinel lymph nodes

Sentinel Node Imaging and Radioguided Surgery in the Era of SPECT/CT and PET/CT: Toward New Interventional Nuclear Medicine Strategies

Clinical Application of Sentinel Lymph Node Technology in Early Gastric Carcinoma and Micrometastasis Detection

Update on Sentinel Lymph Node Methods and Pathology in Breast Cancer

Sentinel lymph node biopsy in Chinese patients with large operable breast cancer (≥4 cm): A decade's experience from a single institution.

Sentinel Lymph Node Staging in Early-Stage Cervical Cancer: A Comprehensive Review

Development of tracing technique in detection of sentinel lymph nodes of cNO head and neck squamous cell carcinoma

Nano-tracers for sentinel lymph node detection: current trends in technique and application